Skip to Main Content

Paper Details

Prospective high-throughput genome profiling of advanced cancers: results of the PERMED-01 clinical trial.
Genome Medicine
20
2021
802 "candidate cancer" genes, AGA, BRCA1/2, ERBB2, HRD, KRAS, PERMED, PIK3CA, PTEN deletions, advanced cancers, advanced solid cancer, cancer, gene panel, gene sets, homologous recombination deficiency, metastatic breast cancers, patients, tumor, tumor DNA
Author NameAffiliation
Daniel BirnbaumInstitut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Aix-Marseille University
  • 1 - 1

Datasets

Release 1.2